A. L. Kabir, “Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A single center Study”, Planet (Barisal), vol. 7, no. 01, pp. 255–266, Feb. 2024.